Almac Group's Diagnostics Business Unit has opened a new companion diagnostic (CDx) development facility located in the Research Triangle Park region of North Carolina. The North Carolina facility will provide a US base to support Almac's increased demand for its CDx development partnerships as well as a CLIA-accredited laboratory to support the downstream delivery of assays for patient testing.

The laboratory is equipped with microarray and qPCR platforms appropriate for companion diagnostic development and will operate both research-use-only and clinical diagnostic tests. Plans are also in place to add additional technology platforms including NGS in the coming year.

Source: Almac